Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in EDIT — Editas Medicine, Inc.

CIK 1037389 NEW YORK, NY
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,999,297
-$1,811,938 QoQ
Shares Held
2,468,919
-37.8% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 216 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. EDIT ranks #61 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in EDIT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,999,297 2,468,919
2026-03-31 $9,811,235 3,972,160
2025-12-31 $6,231,544 3,039,778
2025-09-30 $4,432,578 1,277,400
2025-06-30 $1,954,480 888,400
2025-03-31 $1,198,239 1,032,965
2024-12-31 $1,842,832 1,451,049
2024-06-30 $459,663 98,429
2024-03-31 $6,666,261 898,418
2023-12-31 $5,139,962 507,400
2023-09-30 $503,100 64,500
2023-06-30 $1,286,349 156,300
2022-03-31 $17,182,668 903,400
2021-12-31 $6,056,055 228,100
2021-06-30 $7,929,600 140,000
2021-03-31 $19,148,934 455,927
2020-09-30 $2,977,166 106,100
2020-06-30 $5,918,958 200,100
2020-03-31 $5,966,847 300,900